G Ital Cardiol Vol 8 Ottobre 2007 patients undergoing radical prostatectomy. Transfusion 1998; 38: 924-31. 480. Jurkovitz CT, Abramson JL, Vaccarino LV, Weintraub WS, McClel<strong>la</strong>n WM. Association of high serum creatinine and anemia increases the risk of coronary events: results from the prospective community-based atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 2003; 14: 2919-25. 481. Nelson AH, Fleisher LA, Rosenbaum SH. Re<strong>la</strong>tionship between posto<strong>per</strong>ative anemia and cardiac morbidity in highrisk vascu<strong>la</strong>r patients in the intensive care unit. Crit Care Med 1993; 21: 860-6. 482. Al Falluji N, Lawrence-Nelson J, Kostis JB, Lacy CR, Ranjan R, Wilson AC. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J 2002; 144: 636-41. 483. Nikolsky E, Aymong ED, Halkin A, Grines CL, Cox DA, Garcia E, Mehran R, Tcheng JE, Griffin JJ, Guagliumi G, Stuckey T, Turco M, Cohen DA, Negoita M, Lansky AJ, Stone GW. Impact of anemia in patients with acute myocardial infarction undergoing primary <strong>per</strong>cutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angiop<strong>la</strong>sty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44: 547-53. 484. World Health Organization. Nutritional anaemias: report of a WHO Scientific Group. Technical Report Series No. 405. Geneva: World Health Organization, 1968. 485. Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB, Cushman M. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascu<strong>la</strong>r Health Study. Arch Intern Med 2005; 165: 2214-20. 486. Lee PC, Kini AS, Ahsan C, Fisher E, Sharma SK. Anemia is an independent predictor of mortality after <strong>per</strong>cutaneous coronary intervention. J Am Coll Cardiol 2004; 44: 541-6. 487. Dauerman HL, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol 2005; 96: 1379-83. 488. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, Noveck H, Strom BL. Effect of anaemia and cardiovascu<strong>la</strong>r disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60. 489. Vaglio J, Safley DM, Rahman M, Kosiborod M, Jones P, Thompson R, Krumholz HM, S<strong>per</strong>tus JA. Re<strong>la</strong>tion of anemia at discharge to survival after acute coronary syndromes. Am J Cardiol 2005; 96: 496-9. 490. G<strong>la</strong>gov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory en<strong>la</strong>rgement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-5. 491. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med 1959; 27: 375-88. 492. Antman E, Muller J, Goldberg S, MacAlpin R, Rubenfire M, Tabatznik B, Liang CS, Heupler F, Achuff S, Reichek N, Geltman E, Kerin NZ, Neff RK, Braunwald E. Nifedipine therapy for coronary-artery spasm. Ex<strong>per</strong>ience in 127 patients. N Engl J Med 1980; 302: 1269-73. 493. Prizel KR, Hutchins GM, Bulkley BH. Coronary artery embolism and myocardial infarction. Ann Intern Med 1978; 88: 155-61. 494. Bugiardini R. Normal coronary arteries: clinical implications and further c<strong>la</strong>ssification. Herz 2005; 30: 3-7. 495. Bugiardini R, Manfrini O, De Ferrari GM. Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med 2006; 166: 1391-5. 496. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS. Systematic review: transient left ven- 674 tricu<strong>la</strong>r apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004; 141: 858-65. 497. Gianni M, Dentali F, Grandi AM, Sumner G, Hira<strong>la</strong>l R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006; 27: 1523-9. 498. Hasin Y, Danchin N, Filippatos GS, Heras M, Janssens U, Leor J, Nahir M, Parkhomenko A, Thygesen K, Tubaro M, Wallentin LC, Zakke I. Recommendations for the structure, organization, and o<strong>per</strong>ation of intensive cardiac care units. Eur Heart J 2005; 26: 1676-82. 499. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pep<strong>per</strong> J, Sechtem U, Simoons M, Thygesen K, Priori SG, B<strong>la</strong>nc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL. Guidelines on the management of stable angina pectoris: executive summary. The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006; 27: 1341-81. 500. Rahimi K, Watz<strong>la</strong>wek S, Thiele H, Secknus MA, Hayerizadeh BF, Niebauer J, Schuler G. Incidence, time course, and predictors of early malignant ventricu<strong>la</strong>r arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J 2006; 27: 1706-11. 501. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet JP. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005; 149: 67-73. 502. Budaj A, Brieger D, Steg PG, Goodman SG, Dabbous OH, Fox KA, Avezum A, Cannon CP, Mazurek T, F<strong>la</strong>ther MD, Van De Werf F. Global patterns of use of antithrombotic and antip<strong>la</strong>telet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003; 146: 999-1006. 503. Fox KA, Goodman SG, Anderson FA Jr, Granger CB, Moscucci M, F<strong>la</strong>ther MD, Spencer F, Budaj A, Dabbous OH, Gore JM. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1414-24. 504. Granger CB, Steg PG, Peterson E, Lopez-Sendon J, Van de Werf F, Kline-Rogers E, Allegrone J, Dabbous OH, Klein W, Fox KA, Eagle KA. Medication <strong>per</strong>formance measures and mortality following acute coronary syndromes. Am J Med 2005; 118: 858-65. 505. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline- Rogers E, Eagle KA. Impact of combination evidencebased medical therapy on mortality in patients with acute coronary syndromes. Circu<strong>la</strong>tion 2004; 109: 745-9. 506. Norhammar A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L. Under utilisation of evidence-based treatment partially exp<strong>la</strong>ins for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838-44. 507. Roe MT, Peterson ED, Pol<strong>la</strong>ck CV Jr, Newby LK, Li Y, Christenson RH, Peacock WF, Fesmire FM, Diercks D, Kirk JD, Smith SC Jr, Ohman EM, Gibler WB. Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes. Ann Emerg Med 2005; 45: 355-62. 508. Stenestrand U, Lindback J, Wallentin L. Hospital therapy traditions influence long-term survival in patients with
acute myocardial infarction. Am Heart J 2005; 149: 82-90. 509. Ellerbeck EF, Kresowik TF, Hemann RA, Mason P, Wiblin RT, Marciniak TA. Impact of quality improvement activities on care for acute myocardial infarction. Int J Qual Health Care 2000; 12: 305-10. 510. Flynn MR, Barrett C, Cosio FG, Gitt AK, Wallentin L, Kearney P, Lonergan M, Shelley E, Simoons ML. The Cardiology Audit and Registration Data Standards (CARDS), European data standards for clinical cardiology practice. Eur Heart J 2005; 26: 308-13. 511. LaBresh KA, Ellrodt AG, Gliklich R, Liljestrand J, Peto R. Get with the guidelines for cardiovascu<strong>la</strong>r secondary prevention: pilot results. Arch Intern Med 2004; 164: 203-9. 512. Mehta RH, Das S, Tsai TT, No<strong>la</strong>n E, Kearly G, Eagle KA. Quality improvement initiative and its impact on the management of patients with acute myocardial infarction. Arch Intern Med 2000; 160: 3057-62. 675 <strong>Linee</strong> <strong>guida</strong> <strong>per</strong> <strong>la</strong> <strong>diagnosi</strong> e il trattamento delle SCA-NSTE 513. Mehta RH, Montoye CK, Faul J, Nagle DJ, Kure J, Raj E, Fattal P, Sharrif S, Am<strong>la</strong>ni M, Changezi HU, Skorcz S, Bailey N, Bourque T, LaTarte M, McLean D, Savoy S, Werner P, Baker PL, DeFranco A, Eagle KA. Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use. The American College of Cardiology Acute Myocardial Infarction Guidelines Applied in Practice Project in Michigan: Flint and Saginaw Expansion. J Am Coll Cardiol 2004; 43: 2166-73. 514. Mehta RH, Montoye CK, Gallogly M, Baker P, Blount A, Faul J, Roychoudhury C, Borzak S, Fox S, Franklin M, Freundl M, Kline-Rogers E, LaLonde T, Orza M, Parrish R, Satwicz M, Smith MJ, Sobotka P, Winston S, Riba AA, Eagle KA. Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. JAMA 2002; 287: 1269-76.
- Page 1 and 2:
Tradotto da Guidelines for the diag
- Page 3 and 4:
Prefazione Le linee guida ed i docu
- Page 5 and 6:
campo in continua evoluzione, è ve
- Page 7 and 8:
da un’intensa attivazione piastri
- Page 9 and 10:
nalisi in tempo reale del tratto ST
- Page 11 and 12:
pendente di mortalità a lungo term
- Page 13 and 14:
del torace, dalla TC e dall’angio
- Page 15 and 16:
In assenza di controindicazioni, ne
- Page 17 and 18:
Theroux ’88 Cohen ’90 RISC ’9
- Page 19 and 20:
di anticoagulanti pre-randomizzazio
- Page 21 and 22:
I pazienti sono stati randomizzati
- Page 23 and 24:
Oltre all’OASIS-5, il fondaparinu
- Page 25 and 26: emorragiche gravi secondo i criteri
- Page 27 and 28: PRISM ’98 PRISM-PLUS ’98 PARAGO
- Page 29 and 30: di routine degli inibitori della GP
- Page 31 and 32: izione dell’aggregazione piastrin
- Page 33 and 34: fase ospedaliera fosse stato osserv
- Page 35 and 36: questo contesto clinico nel ridurre
- Page 37 and 38: ci, agli effetti antinfiammatori e
- Page 39 and 40: zienti che hanno avuto una SCA-NSTE
- Page 41 and 42: 6.1.2 Impatto del sanguinamento sul
- Page 43 and 44: di una ridotta funzione renale, di
- Page 45 and 46: ne che deponeva per un maggiore eff
- Page 47 and 48: zione del rischio di morte a 2 anni
- Page 49 and 50: Tabella 9. Stadi della nefropatia c
- Page 51 and 52: dei livelli di troponina non correl
- Page 53 and 54: del medico devono essere prese su b
- Page 55 and 56: - assenza di elevazione delle tropo
- Page 57 and 58: naia, di pazienti sono in grado di
- Page 59 and 60: acute myocardial infarction and 1-y
- Page 61 and 62: 78. Aviles RJ, Askari AT, Lindahl B
- Page 63 and 64: Smith NL, Wahl PW, Wagner EH, Furbe
- Page 65 and 66: Ebrahimi R, Hamon M, Rasmussen LH,
- Page 67 and 68: larization. EPIC Investigators. Eva
- Page 69 and 70: 296. Avanzas P, Arroyo-Espliguero R
- Page 71 and 72: Diabetes and Cardiovascular Disease
- Page 73 and 74: Greinacher A. Heparin-induced throm
- Page 75: 450. Go AS, Chertow GM, Fan D, McCu
Change language